Chronic Progressive Multiple Sclerosis:Serial Magnetic Resonance Brain Imaging Over Six Months
Ann Neurol 26:248-256, Koopmans,R.A.,et al, 1989
Intrathecal Baclofen for Severe Spinal Spasticity
NEJM 320:1517-1521, 1553-15551989., Penn,R.D.,et al, 1989
Intrathecal Baclofen for Long-Term Treatment of Spasticity:A Multi-Centre Study
JNNP 52:933-939, Ochs,G.,et al, 1989
Magnetism, A New Method for Stimulation of Nerve and Brain
JAMA 262:538-541, Hallett,M.&Cohen,L.G., 1989
Accuracy of Self-Reported Disability in Patients with Parkinsonism
Arch Neurol 46:955-959, Brown,R.G.,et al, 1989
Interrater Reliability of the NIH Stroke Scale
Arch Neurol 46:660-662, Goldstein,L.B.,et al, 1989
Cognitive Loss in Multiple Sclerosis
Arch Neurol 46:162-167, Franklin,G.M.,et al, 1989
Correlation of Magnetic Resonance Imaging with Neuropsychological Testing in Multiple Sclerosis
Neurol 39:161-166, Rao,S.M.,et al, 1989
Consensus and Controversy in Neurologic Practice, The Case of Steroid Treatment in Multiple Sclerosis
Arch Neurol 46:322, Menken,M., 1989
Quantitative Magnetic Resonance Imaging in Multiple Sclerosis:The Effect of High Dose Intravenous Methylprednisolone
JNNP 52:14-17, Kesselring,J.,et al, 1989
Clinicopath Conf
Primary (Granulomatous) Angiitis of Central Nervous System, Case Record 8-1989, NEJM 320:514-5249., , 1989
The Prevalence of Primary Sjogren's Syndrome in a Multiple Sclerosis Population
Ann Neurol 25:95-98, Noseworthy,J.H.,et al, 1989
Multiple Sclerosis-Like Illness Occurring with Human Immunodeficiency Virus Infection
Neurol 39:324-329, Berger,J.R.,et al, 1989
Chronic Myelopathies Associated with HTLV-I, A Clinical, Serologic, and Immunovirologic Study of 10 Patients in France
Arch Neurol 46:255-260, Gout,O.,et al, 1989
Clinical Significance of Cerebrospinal Fluid Tests for Neurosyphilis
Ann Neurol 25:50-55, Davis,L.E.&Schmitt,J.W., 1989
Significance of the Argyll Robertson Pupil in Clinical Medicine
Am J Med 86:199-202, Dacso,C.C.&Bortz,D.L., 1989
Hemorrhagic Shock and Encephalopathy:Clinical, Pathologic, and Biochemical Features
J Pediatr 114:194-203, Levin,M.,et al, 1989
Brain-Stem Auditory Evoked Potential Abnormalities with Unilateral Brain-Stem Lesions Demonstrated by MRI
Arch Neurol 46:295-299, Markand,O.N.,et al, 1989
Serial Magnetic Resonance Scanning in Multiple Sclerosis:A Second Prospective Study in Relapsing Patients
Ann Neurol 25:43-49, Willoughby,E.W.,et al, 1989
Benign Versus Chronic Progressive Multiple Sclerosis:Magnetic Resonance Imaging Features
Ann Neurol 25:74-81, Koopmans,R.A.,et al, 1989
Short-Term Outcomes of Skull Fracture:A Population-Based Study of Survival and Neurologic Complications
Neurol 39:96-102, Wiederholt,W.C.,et al, 1989
Concurrence of Multiple Sclerosis and Inflammatory Bowel Disease
NEJM 321:762-763, Sadovnick,A.D.,et al, 1989
Relative Diagnostic Value of Cerebrospinal Fluid Kappa Chains in MS:Comparison with Other Immunoglobulin Tests
Neurol 39:964-968, Rudnick,R.A.,et al, 1989
Patterns of Neurologic Involvement in Multiple Sclerosis
Neurol 39:1235-1238, Kurtzke,J.F., 1989
Magnetic Resonance Imaging of Spinal Cord Lesions in Multiple Sclerosis
JNNP 52:459-466, Honig,L.S.&Sheremata,W.A., 1989
A Referendum on Clinical Trial Research in Multiple Sclerosis:Opinion of Jekyll Island Workshop
Neurol 39:977-981, Noseworthy,J.H.,et al, 1989
Isolation of Herpes Simplex Virus Type 1 During First Attack of Multiple Sclerosis
Ann Neurol 26:283-285, Bergstrom,T.,et al, 1989
Diagnosis of Multiple Sclerosis, Remains Essentially Clinical Though Silent Lesions Can Now be Identified
BMJ 299:635-637, McDonald,W.I., 1989
Amantadine Treatment of Fatigue Associated with Multiple Sclerosis
Arch Neurol 46:676-680, Cohen,R.A.&Fisher,M., 1989
Relative Efficacy of Intravenous Methylprednisolone and ACTH in the Treatment of Acute Relapse in MS
Neurol 39:969-971, Thompson,A.J.,et al, 1989
Double-Blind Study of True vs. Sham Plasma Exchange in Patients Treated with Immunosuppression for Acute Attacks of MS
Neurol 39:1143-1149, Weiner,H.L.,et al, 1989
Randomised Double Blind Controlled Trial of Cyclosporin in Multiple Sclerosis
JNNP 52:559-565, Rudge,P.,et al, 1989
A Placebo-Controlled, Randomized, Clinical Trial of Azathioprine with & without Methylpred in MS
Neurol 39:1018-1026, Ellison,G.W.,et al, 1989
Immunological Treatment for Multiple Sclerosis
Editorial, Lancet 1:699-7011989., , 1989
Treatment of Cerebellar Tremors with Carbamazepine:A Controlled Trial with Long-Term Follow-Up
Neurol 39:1113-1115, Sechi,G.P.,et al, 1989
An Epidemiologic Study of Headache Among Adolescents and Young Adults
JAMA 261:2211-2216, Linet,M.S.,et al, 1989
Tuberculous Meningitis in Children:Treatment with Isoniazid and Rifampicin for Twelve Months
J Pediatr 114:875-879, Visudhiphan,P.&Chiemchanya,S., 1989
Central Nervous System Manifestations of Lyme Disease
Arch Neurol 46:790-795, Pachner,A.R.,et al, 1989
Lyme Neuroborreliosis:Central Nervous System Manifestations
Neurol 39:753-759, Halperin,J.J.,et al, 1989
Brain Damage by Neonatal Hypoglycaemia
Editorial, Lancet 1:882-8831989., , 1989
Demyelinating Diseases
In Rowlands Merritt's Textbk of Neurology, Lea & Febiger, Phila, 8th Ed, p. 749, Sibley,W.A.,et al, 1989
Clinical Presentations of Vascular Malformations of the Brain Stem:Comparison of Angiographically Positive and Negative Types
JNNP 52:167-175, Abe,M.,et al, 1989
Sneddon Syndrome:CT, Arteriography, and MR Imaging
J Comput Assist Tomogr 13:119-122, Blom,R.J., 1989
Severely Threatening Events and Marked Life Difficulties Preceding Onset or Exacerbation of MS
JNNP 52:8-13, Grant,I.,et al, 1989
The Disability Status Scale for Multiple Sclerosis:Apologia Pro DSS Sau
Neurol 39:291-302, Kurtzke,J.F., 1989
Scales for Rating Impairment in Multiple Sclerosis:A Critique
Neurol 38:1793-1798, Willoughby,E.W.&Paty,D.W., 1988
Criteria for an Increased Specificity of MRI Interpretation in Elderly with Suspected Multiple Sclerosis
Neurol 38:1822-1825, Fazekas,F.,et al, 1988
Amantadine, Fatigue, and Multiple Sclerosis
Arch Neurol 45:1104-1106, Rosenberg,G.A.&Appenzeller,O., 1988
Correlation of Neuropsychological and MRI Findings in Chronic/Progressive Multiple Sclerosis
Neurol 38:1826-1829, Franklin,G.M.,et al, 1988
Pain Syndromes in Multiple Sclerosis
Neurol 38:1830-1834, Moulin,D.E.,et al, 1988